Skip to content

Geron GERN Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

Incyte logo
IncyteINCY
Arcus Biosciences logo
Arcus BiosciencesRCUS
Tango Therapeutics logo
Tango TherapeuticsTNGX
Eli Lilly logo
Eli LillyLLY
GRAIL, Inc. logo
GRAIL, Inc.GRAL

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$878.88M-8.6%
Enterprise value$964.15M-6.2%
P/S4.7×-172×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's accrued manufacturing costs?
Geron (GERN) reported accrued manufacturing costs of $9.49M in Q1 2026.
How has Geron's accrued manufacturing costs changed year-over-year?
Geron's accrued manufacturing costs decreased by 1.2% year-over-year, from $9.6M to $9.49M.
What is the long-term trend for Geron's accrued manufacturing costs?
Over 5 years (2020 to 2025), Geron's accrued manufacturing costs has grown at a 30.0% compound annual growth rate (CAGR), from $8.22M to $30.5M.